| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |